Furthermore, external validation from our cohort revealed the elevated SLPI and MMP9 mRNA levels in aortic valve tissues of CAVD groups compared with control groups. The gene discussed is SLPI; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.